Solara Active Pharma Sciences Ltd

SOLARAPP1

Company Profile

  • Business description

    Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.

  • Contact

    Phase II - CSIR Road
    Module No. 601, 602, 603, Ticel Bio Park
    Taramani
    ChennaiTN600113
    IND

    T: +91 4447406200

    https://www.solara.co.in

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    2,924

Stocks News & Analysis

stocks

Procter & Gamble earnings: Frigid sales and margins don’t suggest cracks in its standing

North America was a notable blemish, down 2% on an organic basis.
stocks

Our view on Santos after production is ramped up

Barossa at 75% capacity and Pikka undergoing commissioning.
stocks

GE Aerospace earnings: No good deed goes unpunished

We’ve raised our fair value estimate of GE Aerospace stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,189.9015.700.17%
CAC 408,143.055.84-0.07%
DAX 4024,900.7144.240.18%
Dow JONES (US)49,098.71285.30-0.58%
FTSE 10010,143.446.61-0.07%
HKSE26,749.51119.550.45%
NASDAQ23,501.2465.220.28%
Nikkei 22553,846.87157.980.29%
NZX 50 Index13,448.24108.63-0.80%
S&P 5006,915.612.260.03%
S&P/ASX 2008,860.1015.000.17%
SSE Composite Index4,136.1613.590.33%

Market Movers